You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
|
|---|---|
| Published in |
The Lancet, July 2017
|
| DOI | 10.1016/s0140-6736(17)31281-3 |
| Pubmed ID | |
| Authors |
Peter G Gibson, Ian A Yang, John W Upham, Paul N Reynolds, Sandra Hodge, Alan L James, Christine Jenkins, Matthew J Peters, Guy B Marks, Melissa Baraket, Heather Powell, Steven L Taylor, Lex E X Leong, Geraint B Rogers, Jodie L Simpson |
X Demographics
The data shown below were collected from the profiles of 270 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 34 | 13% |
| Spain | 30 | 11% |
| United Kingdom | 30 | 11% |
| Australia | 11 | 4% |
| Japan | 9 | 3% |
| Venezuela, Bolivarian Republic of | 5 | 2% |
| Saudi Arabia | 5 | 2% |
| Canada | 4 | 1% |
| Ecuador | 4 | 1% |
| Other | 33 | 12% |
| Unknown | 105 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 178 | 66% |
| Practitioners (doctors, other healthcare professionals) | 57 | 21% |
| Scientists | 28 | 10% |
| Science communicators (journalists, bloggers, editors) | 7 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 497 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 497 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 70 | 14% |
| Other | 59 | 12% |
| Student > Ph. D. Student | 50 | 10% |
| Student > Master | 38 | 8% |
| Student > Bachelor | 36 | 7% |
| Other | 113 | 23% |
| Unknown | 131 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 222 | 45% |
| Pharmacology, Toxicology and Pharmaceutical Science | 23 | 5% |
| Immunology and Microbiology | 22 | 4% |
| Biochemistry, Genetics and Molecular Biology | 19 | 4% |
| Nursing and Health Professions | 14 | 3% |
| Other | 50 | 10% |
| Unknown | 147 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 287. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2024.
All research outputs
#124,878
of 25,744,802 outputs
Outputs from The Lancet
#1,687
of 42,968 outputs
Outputs of similar age
#2,653
of 327,041 outputs
Outputs of similar age from The Lancet
#26
of 408 outputs
Altmetric has tracked 25,744,802 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,968 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,041 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 408 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.